KBFS
PFE icon

Kohmann Bosshard Financial Services’s Pfizer PFE Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,085
Closed -$51.9K – 489
2025
Q4 		$51.9K Buy
+2,085
New +$52.6K ﹤0.01% 512
2025
Q1 		– Sell
-1,071
Closed -$28.4K – 640
2024
Q4 		$28.4K Buy
+1,071
New +$29.1K ﹤0.01% 389

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kohmann Bosshard Financial Services's PFE Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of Pfizer (PFE) in Q1 2026, closing a stake of 2,085 shares — an estimated $51.9K sold.

Kohmann Bosshard Financial Services first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $51.9K in Q4 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 2,085 Pfizer shares in Q1 2026, an estimated $51.9K.
  • Kohmann Bosshard Financial Services first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's Pfizer position peaked at $51.9K in Q4 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.